Benadryl Allergy Sinus 19 mg / 30 mg Disintegrating Oral Tablet
RxNorm 1294562
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1294562 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Benadryl Allergy Sinus 19 mg / 30 mg Disintegrating Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SY
Synonym (SY):
Benadryl Allergy Sinus (diphenhydramine hydrochloride 12.5 mg (diphenhydramine citrate 19 mg) / pseudoephedrine hydrochloride 30 mg) Disintegrating Oral Tablet
(Atom ID: 6356350)
TMSY
Tall Man Lettering Synonym (TMSY):
Benadryl Allergy Sinus (diphenhydrAMINE hydrochloride 12.5 mg (diphenhydrAMINE citrate 19 mg) / pseudoephedrine hydrochloride 30 mg) Disintegrating Oral Tablet
(Atom ID: 6377695)
PSN
Prescribable Name (PSN):
Benadryl Allergy Sinus 19 mg / 30 mg Disintegrating Oral Tablet
(Atom ID: 6372140)
SBD
Semantic Branded Drug (SBD):
Diphenhydramine hydrochloride 12.5 mg / pseudoephedrine hydrochloride 30 mg Disintegrating Oral Tablet [Benadryl Allergy Sinus]
(Atom ID: 12370900)
TMSY